SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-17-049549
Filing Date
2017-08-04
Accepted
2017-08-04 13:54:09
Documents
2

Document Format Files

Seq Description Document Type Size
1 S-3/A a17-18483_2s3a.htm S-3/A 123059
2 EX-5.1 a17-18483_2ex5d1.htm EX-5.1 48848
  Complete submission text file 0001104659-17-049549.txt   172978
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-219567 | Film No.: 171008005
SIC: 2834 Pharmaceutical Preparations